| 269 - 274 |
Interview with Wiestaw Szelejewski, director of the Pharmaceutical Institute in Warsaw
[Anonymous] |
| 279 - 280 |
People in Polish chemistry: Wiestaw Szelejewski
[Anonymous] |
| 282 - 283 |
The national pharmaceuticals industry at the start of the 21st century: Opportunities and threats
[Anonymous] |
| 294 - 299 |
Anthracycline antibiotics
Grynkiewicz G |
| 300 - 310 |
Syntheses of vitamin D metabolites and analogs. Retrospect and prospects
Ryznar T, Krupa M, Kutner A |
| 311 - 313 |
Examination of the bioequivalence of generic pharmaceutical products
Kobylinska K |
| 314 - 316 |
The technology of modern drug forms
Slifirski P |
| 317 - 323 |
Capillary electrophoresis - a high-performance technique in the analysis of pharmaceuticals
Maruszak W |
| 324 - 327 |
The history of the cytostatic generic domestic drug Mitoxantrone in Poland
Lypacewicz MK |
| 328 - 334 |
History of the Pharmaceutical Institute in Warsaw
Jaworska R |
| 335 - 336 |
Prof Tadeusz Witold Gumulka (1910-1989)
Gumulka W |
| 336 - 337 |
Prof. dr Pawel Nantka-Namirski (1911-1993)
Kaczmarek L |
